BMS-986345
Follicular Helper T-Cell Lymphoma
City of Hope Medical CenterPhase 2Active
CCC
50/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 35/ 100
- Competitive Position
- 81/ 100
Competitive context
9 Active assets in the Follicular Helper T-Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FILGRASTIM City of Hope Medical Center | Phase 3 | B |
PREDNISONE TABLETS City of Hope Medical Center | Phase 2 | B |
Cyclophosphamide City of Hope Medical Center | Phase 2 | B |
Inno-206 City of Hope Medical Center | Phase 2 | B |
(+)-VINCRISTINE City of Hope Medical Center | Phase 2 | B |
View all 9 →
Same molecule, other indications
BMS-986345 is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →